<style face="normal" font="default" size="100%">Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenetics of treatments for inflammatory bowel disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Genetic determinants for methotrexate response in juvenile idiopathic arthritis.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of oxidative stress mediated by glutathione-s-transferase in thiopurines' toxic effects.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Personalized therapies in pediatric inflammatory and autoimmune diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenomics in pediatric leukemia.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence.</style>